Capital Research Global Investors
EXEL icon

Capital Research Global Investors’s Exelixis EXEL Stock Holding History

Capital Research Global Investors’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-22,565,030
Closed -$138M – 428
2013
Q4 		$138M Buy
22,565,030
+17,330
+0.1% +$95.5K 0.05% 249
2013
Q3 		$131M Buy
22,547,700
+381,800
+2% +$1.98M 0.05% 249
2013
Q2 		$101M Buy
+22,165,900
New +$105M 0.04% 262

Other funds holding EXEL

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Research Global Investors's EXEL Position: Q1 2014 in Review

Capital Research Global Investors sold out of Exelixis (EXEL) in Q1 2014, closing a stake of 22,565,030 shares — an estimated $138M sold.

Capital Research Global Investors first reported a position in EXEL in Q2 2013 and held it in 3 quarters. The position peaked at $138M in Q4 2013. 152 funds tracked by Wall St. Rank hold EXEL as of Q1 2014.

  • Capital Research Global Investors reported no remaining Exelixis position as of Q1 2014 after selling out during the quarter.
  • Capital Research Global Investors sold 22,565,030 Exelixis shares in Q1 2014, an estimated $138M.
  • Capital Research Global Investors first reported a position in Exelixis in Q2 2013 and held it in 3 quarters.
  • Capital Research Global Investors's Exelixis position peaked at $138M in Q4 2013.
  • 152 funds tracked by Wall St. Rank held Exelixis as of Q1 2014.

Based on Capital Research Global Investors's 13F filing for Q1 2014, filed 15 May 2014.